I am a
Home I AM A Search Login

Papers of the Week

2020 May 14


Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures.


Chung SS, French JA, Kowalski J, Krauss GL, Lee S K, Maciejowski M, Rosenfeld WE, Sperling MR, Mizne S, Kamin M
Neurology. 2020 May 14.
PMID: 32409485.


To evaluate the efficacy and safety of adjunctive cenobamate 200 mg/d in patients with uncontrolled focal (partial-onset) seizures despite treatment with 1 to 3 antiepileptic drugs.